Patient- and physician-rated measures demonstrate the effectiveness of ropinirole in the treatment of restless legs syndrome

Clinical Neuropharmacology

Volumn 31, Issue 5, 2008, Pages 281-286

  Kushida, Clete A ^a   Geyer, James ^b   Tolson, Jerry M ^c   Asgharian, Afsaneh ^c  

^a STANFORD UNIVERSITY   (United States)

^b Neurology Consultants PC   (United States)

^c GLAXOSMITHKLINE   (United States)

Author keywords

Patient Global Improvement; Restless legs syndrome; RLS; Ropinirole

Indexed keywords

PLACEBO; ROPINIROLE; INDOLE DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL ASSESSMENT; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EVENING DOSAGE; HEADACHE; HUMAN; INTERNATIONAL RESTLESS LEGS SYNDROME STUDY GROUP RATING SCALE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; NAUSEA; NEUROLOGIC EXAMINATION; OUTCOME ASSESSMENT; PATIENT GLOBAL IMPROVEMENT SCALE; PATIENT SATISFACTION; PHYSICIAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SOMNOLENCE; SYMPTOM; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VOMITING; ADOLESCENT; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HOSPITALIZATION; MALE; METHODOLOGY; MIDDLE AGED; PATHOPHYSIOLOGY; PATIENT PARTICIPATION; PHYSICIAN ATTITUDE;

ADOLESCENT; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; INDOLES; MALE; MIDDLE AGED; PATIENT PARTICIPATION; PHYSICIAN'S ROLE; RESTLESS LEGS SYNDROME; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; YOUNG ADULT;

EID: 65849366728     PISSN: 03625664     EISSN: None     Source Type: Journal    
DOI: 10.1097/WNF.0b013e31815a3eec     Document Type: Article

References (16)

1. Allen RP, Walters A, Montplaisir J, et al. Restless Legs Syndrome Prevalence and Impact. REST general population study. Arch Intern Med 2005; 165:1286-1292.
2. Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J Psychosom Res 2002;53: 547-554.
3. Phillips B, Young T, Finn L, et al. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-2141.
4. Allen RP, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003;4:101-119.
5. Adler CH, Hauser RA, Sethi K, et al. Ropinirole for restless legs syndrome: a placebo-controlled crossover trial. Neurology 2004;62:1405-1407.
6. Trenkwalder C, Garcia-Borreguero D, Montagna P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004;75:92-97.
7. Walters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov Disord 2004;19:1414-1423.
8. Allen R, Becker PM, Bogan R, et al. Ropinirole decreases periodic leg movements and improves sleep parameters in patients with restless legs syndrome. Sleep 2004;27:907-914.
9. Bogan RK, Fry JM, Schmidt MH, et al. Ropinirole in the treatment of patients with restless legs syndrome: a US-based randomized, double-blind, placebo controlled clinical trial. Mayo Clin Proc 2006;81:17-27.
10. Trenkwalder C, Hundemer H, Lledo A, et al. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS Study. Neurology 2004;62: 1391-1397.
11. Winkelman J, Sethi K, Kushida C, et al. Efficacy and safety of pramipexole in restless legs syndrome. Neurology 2006;67:1034-1039.
12. Partinen M, Hirvonen K, Jama L, et al. Efficacy & safety of pramipexole in idiopathic restless legs syndrome: a polysomnographic dose finding study - the PRELUDE study. Sleep Med 2006;7: 407-417.
13. Oertel WH, Stiasny-Kolster K, Bergtholdt B, et al. Efficacy of pramipexole in restless legs syndrome: a six-week, multicenter, randomized, double-blind study (effect-RLS study). Mov Disord 2207;22: 213-219.
14. Hening W, Walters AS, Allen RP, et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med 2004;5:237-246.
15. Walters AS. The International Restless Legs Syndrome Study Group. Toward a better definition of the restless legs syndrome. Mov Disord 1995;10:634-642.
16. Walters AS, LeBrocq C, Dhar A, et al. Validation of the International Restless Legs Syndrome Study Group rating scale for restless legs syndrome. Sleep Med 2003;4:121-132.